Skip to content
buyWeak cluster of 2

Erez Raphael bought $8,980 of DRIO

Chief Executive Officer at DarioHealth Corp.. 10,000 shares at an average of $0.90, traded Aug 16, 2024, filed Aug 20, 2024.

Conviction score
36
Value
$8,980
10,000 shares
Holdings after
1,922,059
+1% from before
From 52-week low
+12%
low $15.82, close $17.66
From 52-week high
-74%
high $67.80, as of Aug 16, 2024

Score components

  • Role
    CEO
    +25
  • Trade size
    $9k at market
    0
  • Relative to holdings
    Under 1% of holdings (0.5%)
    -5
  • Price context
    74% below the 52-week high
    +8
  • Cluster
    2 insiders buying within 14 days
    +8
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (0 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +8.7%, 3m -14.1%, 6m -21.6%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

DRIOOct 12, 2026 · close 5.42
Since filing Aug 20, 2024: -70.5%SPY +42.9% · excess -113.4%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001104659-24-091264, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Aug 16, 2024POpen-market purchase
Common Stock
+2,000$0.89$1,7801,914,059Aug 20, 2024
Aug 16, 2024POpen-market purchase
Common Stock
+3,000$0.90$2,7001,917,059Aug 20, 2024
Aug 19, 2024POpen-market purchase
Common Stock
+5,000$0.90$4,5001,922,059Aug 20, 2024

Related signals

Other insiders at DarioHealth Corp. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
38Weak
DRIObuy
DarioHealth Corp.
Dennis Matheis
director
$100k
14,430 shares
+50%
38Weak
DRIObuy
DarioHealth Corp.
Steven Charles Nelson
President and CCO
$21k
40,000 shares
+73%
18Weak
DRIObuy
DarioHealth Corp.
Steven Charles Nelson
Chief Commercial Officer
$4,546
5,000 shares
+10%
52Moderate
DRIObuy 2
DarioHealth Corp.
Steven Charles Nelson
Chief Commercial Officer
$8,244
10,000 shares
+25%
56Moderate
DRIObuy 2
DarioHealth Corp.
Steven Charles Nelson
Chief Commercial Officer
$12k
15,000 shares
+60%
51Moderate
DRIObuy 2
DarioHealth Corp.
Erez Raphael
Chief Executive Officer
$4,400
5,000 shares
+0%
41Moderate
DRIObuy 2
DarioHealth Corp.
Erez Raphael
Chief Executive Officer
$9,400
10,000 shares
+1%
46Moderate
DRIObuy 2
DarioHealth Corp.
Steven Charles Nelson
Chief Commercial Officer
$14k
15,000 shares
+150%
39Weak
DRIObuy 2
DarioHealth Corp.
Steven Charles Nelson
Chief Commercial Officer
$9,283
10,000 shares
-
6Weak
DRIOsell10b5-1
DarioHealth Corp.
Dennis M McGrath
director
$39k
9,872 shares
-12%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Erez Raphael bought $8,980 of DRIO | InsiderTell